Willingness to accept herpes zoster vaccines and the influencing factors in China
Willingness to accept herpes zoster vaccines and the influencing factors in China
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Herpes zoster increases the burden on the elderly in an aging society. Although an effective vaccine licensed by China Food and Drug Administration in 2019 was introduced into the market in June 2020, the willingness and influencing factors of herpes zoster vaccines in Chinese adults [greater than or equal to] 50-years-old during coronavirus diseas...
Alternative Titles
Full title
Willingness to accept herpes zoster vaccines and the influencing factors in China
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_3104538b2038468a8bddc4c7e598c755
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_3104538b2038468a8bddc4c7e598c755
Other Identifiers
ISSN
1471-2334
E-ISSN
1471-2334
DOI
10.1186/s12879-022-07840-2
